Momenta Pharmaceuticals Inc (MNTA) Return on Investment ROI from the second quarter of 2020 to second quarter of 2019 and for the year 2020, average high and low, overall ranking from Jun 30 2020 to Jun 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Momenta Pharmaceuticals inc   (NASDAQ: MNTA)


Momenta Pharmaceuticals Inc's ROI from its second quarter of 2020 to the second quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Momenta Pharmaceuticals Inc's ROI in the second quarter of 2020?
Momenta Pharmaceuticals Inc recorded a cumulative net loss of $-228 million during 12 months ending in the second quarter of 2020, resulting in a negative return on investment (ROI) of -51.78%.

Within the Healthcare sector 521 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2020 from 0 to 3895.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter
Y / Y Investment Change TTM 2.1 % 7.01 % 17.26 % 25.67 % 13.74 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 452 486 466 357 438
Return On Investment (TTM) -51.78 % -65.23 % -65.64 % -47.5 % -50.44 %
MNTA's Overall Ranking # 3895 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 0.78 % -1.2 % -0.82 % 3.39 % 5.63 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -228 -285 -290 -212 -217

MNTA Company Profile >> Back to MNTA Roi Comparisons >> See Annual MNTA Return On Investment



Return On Investment MNTA's Ranking
Within: No.
Industry # 71
Sector # 522
Overall # 3895

Return On Investment Statistics
High Average Low
-5.36 %
-33.23 %
-65.11 %
(Dec 31 2016)   (Dec 31 2019)







Financial Statements
Momenta Pharmaceuticals Inc's II. Quarter Investments $ 452 Millions MNTA's Balance sheet
Momenta Pharmaceuticals Inc's II. Quarter Income $ -57 Millions Quarterly MNTA's Income Statement
MNTA's Income by Division See MNTA's Income by Division


MNTA Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 512 480 415 407 382
Y / Y Investment Growth 6.71 % 15.69 % 1.94 % 6.49 % 64.46 %
Net Income in Millions -290 -176 -88 -21 -83
Y / Y Net Income Growth - - - - -
Annual Return On Investment -56.62 % -36.68 % -21.23 % -5.16 % -21.79 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MNTA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MNTA's Competitors
Subscribers only: Roi for Momenta Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for MNTA's Customers

Other Ratios
MNTA's Roa MNTA's Inventory Turnover Ratio MNTA's Growth Rates MNTA's Dividend Statistics
MNTA's Profitability Ratios MNTA's Asset Turnover Ratio MNTA's Dividend Growth
MNTA's Roe MNTA's Valuation Ratios MNTA's Financial Strength Ratios MNTA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.